{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T12:04:06Z","timestamp":1772366646246,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bbmt.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbmt.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T02:23:56Z","timestamp":1552357436000},"page":"1486-1491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy"],"prefix":"10.1016","volume":"25","author":[{"given":"Tingting","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgeng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.03.002_bib0001","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0002","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bmt.2017.39","article-title":"Transplant-associated thrombotic microangiopathy: opening Pandora's box","volume":"52","author":"Gavriilaki","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0003","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/bmt.2009.233","article-title":"Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange","volume":"45","author":"Kennedy","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0004","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0005","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1703710","article-title":"Transplantation associated thrombotic microangiopathy: twenty-two years later","volume":"30","author":"Daly","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0006","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0007","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0008","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0009","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/bmt.2016.253","article-title":"Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?","volume":"52","author":"Dhakal","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0010","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1152\/physrev.00003.2016","article-title":"Heme oxygenases in cardiovascular health and disease","volume":"96","author":"Ayer","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0011","doi-asserted-by":"crossref","first-page":"e75927","DOI":"10.1371\/journal.pone.0075927","article-title":"Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0012","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00395-014-0450-9","article-title":"Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology","volume":"109","author":"Czibik","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0013","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/gt.2008.162","article-title":"A cell penetrating heme oxygenase protein protects heart graft against ischemia\/reperfusion injury","volume":"16","author":"Ma","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0014","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jacc.2015.04.064","article-title":"Heme oxygenase-1 gene therapy provides cardioprotection via control of post-ischemic inflammation. An experimental study in a pre-clinical pig model","volume":"66","author":"Hinkel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0015","first-page":"516","article-title":"The role of heme oxygenase-1 in the protection of chronic intermittent hypoxia-induced lung injury in vivo","volume":"38","author":"Han","year":"2015","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0016","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2017-12-819870","article-title":"HO-1hi patrolling monocytes protect against vaso-occlusion in sickle cell disease","volume":"131","author":"Liu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0017","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-3089.2011.00674.x","article-title":"Transgenic expression of human heme oxygenase-1 in pigs confers resistance against xenograft rejection during ex vivo perfusion of porcine kidneys","volume":"18","author":"Petersen","year":"2011","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.trsl.2011.01.003","article-title":"Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction","volume":"157","author":"Novo","year":"2011","journal-title":"Translat Res"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0019","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.transproceed.2010.05.104","article-title":"The in vitro protection of human decay accelerating factor and hDAF\/heme oxygenase-1 transgenes in porcine aortic endothelial cells against sera of Formosan macaques","volume":"42","author":"Tu","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0020","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood-2008-04-152934","article-title":"Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin","volume":"113","author":"Kinderlerer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0021","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.ajpath.2016.07.009","article-title":"Heme oxygenase 1 up-regulates glomerular decay accelerating factor expression and minimizes complement deposition and injury","volume":"186","author":"Detsika","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0022","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/trf.12440","article-title":"Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: a case report","volume":"54","author":"Li","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0023","first-page":"8655","article-title":"N-acetylcysteine protects against liver injure induced by carbon tetrachloride via activation of the Nrf2\/HO-1 pathway","volume":"8","author":"Cai","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0024","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbmt.2018.01.009","article-title":"Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation","volume":"24","author":"Horv\u00e1th","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0026","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/ckj\/sfx081","article-title":"Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea","volume":"10","author":"Brocklebank","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0027","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","article-title":"Eculizumab for congenital atypical hemolytic-uremic syndrome","volume":"360","author":"Gruppo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0028","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"Nurnberger","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1165\/ajrcmb.15.1.8679227","article-title":"Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant- induced lung injury","volume":"15","author":"Choi","year":"1996","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0030","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0031","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume":"130","author":"Gloude","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0032","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.107.07104","article-title":"Pharmacological and clinical aspects of heme oxygenase","volume":"60","author":"Abraham","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0033","doi-asserted-by":"crossref","first-page":"83437","DOI":"10.18632\/oncotarget.13118","article-title":"Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0034","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1165\/rcmb.2006-0331TR","article-title":"The role of heme oxygenase-1 in pulmonary disease","volume":"36","author":"Fredenburgh","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1086\/302729","article-title":"Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema","volume":"66","author":"Yamada","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0036","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.2147\/DDDT.S91823","article-title":"Effect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Design Dev Ther"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0037","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.V94.5.1673","article-title":"Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition","volume":"94","author":"Mason","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0038","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCULATIONAHA.117.027290","article-title":"Potent thrombolytic effect of n-acetylcysteine on arterial thrombi","volume":"136","author":"Martinez de Lizarrondo","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0039","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","article-title":"N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2019.03.002_bib0040","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119301521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119301521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:40:57Z","timestamp":1738010457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119301521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1083879119301521"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.03.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}